OPTIFORM
Live / Registered — Registered and renewed (as of 12 Aug 2026)
What this means for you
Registered since 28 Jun 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jun 2036: the §8 & §9 renewal).
Record
- Serial number
- 86809467
- Registration number
- 4988248
- Mark type
- Word mark
- Filed
- 04 Nov 2015
- Published for opposition
- 12 Apr 2016
- Registered
- 28 Jun 2016
- Current term from
- 28 Jun 2026
- Next maintenance filing
- §8 & §9 renewal, due by 28 Jun 2036 (grace period to 28 Dec 2036)
- Attorney of record
- Vanessa A. Ignacio, Esq.
Goods and services
- Class 042 — Scientific and technological services: Scientific research services; Chemical compound and chemical compound library research and development services; Pharmaceutical research and development, namely, screening drug targets; Pharmaceutical research and development, namely, automated screening of pharmaceutical and chemical compounds; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of oral dose drug development; Conducting scientific feasibility studies; Pharmaceutical research services, namely, screening and identifying optimal active pharmaceutical ingredient (API) forms, optimized final dosing forms, dosing profiles, optimal formulation of pharmaceutical products, determination of drug substance state for enhanced bioavailability, ingredient compatibility screening, solid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product development, optimization of optimal active pharmaceutical ingredient (API) design, formulation of pharmaceutical products and drug product design
Owner
- CATALENT PHARMA SOLUTIONS, INC., Bridgewater, NJ, US
- CATALENT PHARMA SOLUTIONS, INC., Somerset, NJ, US
- CATALENT PHARMA SOLUTIONS, INC., Somerset, NJ, US
Prior registrations
Prosecution history
- 09 Oct 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 12 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Aug 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Aug 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jun 2026 — TEAS SECTION 8 & 9 RECEIVED
- 28 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Dec 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 13 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jan 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Jun 2022 — TEAS SECTION 8 & 15 RECEIVED
- 28 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 May 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 28 Jun 2016 — REGISTERED-PRINCIPAL REGISTER